Market Introduction
A large network of proteins and other molecules that surround, support, and give structure to cells and tissues in the body. The extracellular matrix helps cells attach to, and communicate with, nearby cells, and plays an important role in cell growth, cell movement, and other cell functions. The extracellular matrix is also involved in repairing damaged tissue. Abnormal changes in the extracellular matrix may lead to the development of certain diseases, such as cancer.
Moreover, increasing incidences of trauma and cardiovascular diseases and increasing vascular reconstruction procedures. However, challenges during the usage of decellularized extracellular matrix are expected to restrict the market growth during the forecast period.
The pandemic has increased demand for medical devices, which can used in-home care. The region is witnessing an increase in the number of patients being admitted to intensive care units (ICU), an increasing number of drugs that pose multiple diagnostic and therapeutic challenges to strained health systems, leading to an increase in medical devices. There have been changes in staff assignments and working hours and the implementation of strict infection control and social distancing measures. In addition, they also face mental, physical, emotional, and financial challenges. COVID-19 does not currently have any specific antiviral drug treatment, so treatment for the disease is mainly focused on symptomatic treatment and oxygen therapy. It is recommended that inflammatory factors and lymphocyte subsets be monitored throughout the illness. Current treatment of severe type and critical type COVID-19 patients in the Middle East and Africa is key to controlling the rising number of deaths. The government is currently engaged in several efforts to discover, repurpose, and/or develop preventive and treatment options for COVID-19. The pharmaceutical industry in Sub-Saharan Africa is poorly developed and cannot effectively meet the prevention and treatment needs of the region for the biomedical management of COVID-19.
Market Overview and Dynamics
The Middle East & Africa extracellular matrix market is expected to reach US$ 2,278.4 Thousands by 2028 from US$ 1,485.2 Thousands in 2021. The market is estimated to grow at a CAGR of 6.3% from 2021–2028. The potential of regenerative medicine that facilitates tissue regeneration in the affected area reduced the requirement of tissue transplant. The extracellular matrix is derived from a readily available tissue source, it can stimulate tissue growth in vivo with minimal inflammation, and it is available off the shelf. These advantages of the extracellular matrix enable the ideal soft tissue replacement treatment procedures to repair contour defects. The increasing vascular reconstruction or plastic surgeries are anticipated to grow the extracellular matrix during the forecast period.
Key Market Segments
In terms of raw material, the porcine segment accounted for the largest share of the Middle East & Africa extracellular matrix market in 2020. In terms of application, the soft tissue repair segment accounted for the largest share of the Middle East & Africa extracellular matrix market in 2020.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the extracellular matrix market in Middle East & Africa are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Medtronic, Merck Kgaa, Smith & Nephew, Coloplast Group, Baxter, DSM, and Cook Biotech.
Reasons to Buy Report
MIDDLE EAST & AFRICA EXTRACELLULAR MATRIX MARKET SEGMENTATION
By Raw Material
By Application
By Country
Companies Mentioned
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 1,485.2 thousand |
| Market Size by 2028 | US$ 2,278.4 thousand |
| CAGR (2021 - 2028) | 6.3% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Raw Material
|
|
Regions and Countries Covered
|
|
| Middle East and Africa | South Africa, Saudi Arabia, UAE, Rest of Middle East and Africa |
| Market leaders and key company profiles |
|
The Middle East and Africa Extracellular Matrix Market is valued at US$ 1,485.2 thousand in 2021, it is projected to reach US$ 2,278.4 thousand by 2028.
As per our report Middle East and Africa Extracellular Matrix Market, the market size is valued at US$ 1,485.2 thousand in 2021, projecting it to reach US$ 2,278.4 thousand by 2028. This translates to a CAGR of approximately 6.3% during the forecast period.
The Middle East and Africa Extracellular Matrix Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East and Africa Extracellular Matrix Market report:
The Middle East and Africa Extracellular Matrix Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East and Africa Extracellular Matrix Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East and Africa Extracellular Matrix Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+1 646 791 7070
sales@businessmarketinsights.com
Get Free Sample For Middle East and Africa Extracellular Matrix Market
